Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer

FEBS Letters

Volumn 588, Issue 10, 2014, Pages 1973-1982

  Goto, Yusuke ^a   Nishikawa, Rika ^a   Kojima, Satoko ^b   Chiyomaru, Takeshi ^c   Enokida, Hideki ^c   Inoguchi, Satoru ^c   Kinoshita, Takashi ^a   Fuse, Miki ^a   Sakamoto, Shinichi ^a   Nakagawa, Masayuki ^c   Naya, Yukio ^b   Ichikawa, Tomohiko ^a   Seki, Naohiko ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

microRNA; miR 224; Prostate cancer; TPD52; Tumour suppressor

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 224; PROTEIN TPD52; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER STAGING; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MIDDLE AGED; ONCOGENE; ONCOGENE TPD52; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; UPREGULATION; VERY ELDERLY;

MICRORNA; MIR-224; PROSTATE CANCER; TPD52; TUMOUR SUPPRESSOR;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 84900413202     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.04.020     Document Type: Article

References (45)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J. Clin. 63 2013 11 30
2. J. Sturge, M.P. Caley, and J. Waxman Bone metastasis in prostate cancer: emerging therapeutic strategies Nat. Rev. Clin. Oncol. 8 2011 357 368
3. K.N. Chi, A. Bjartell, D. Dearnaley, F. Saad, F.H. Schroder, C. Sternberg, B. Tombal, and T. Visakorpi Castration-resistant prostate cancer: from new pathophysiology to new treatment targets Eur. Urol. 56 2009 594 605
4. R.W. Carthew, and E.J. Sontheimer Origins and mechanisms of miRNAs and siRNAs Cell 136 2009 642 655
5. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
6. A. Esquela-Kerscher, and F.J. Slack Oncomirs - microRNAs with a role in cancer Nat. Rev. Cancer 6 2006 259 269
7. M. Fuse et al. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer J. Hum. Genet. 57 2012 691 699
8. M. Fuse et al. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1 Int. J. Oncol. 38 2011 1093 1101
9. S. Kojima et al. Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer Br. J. Cancer 106 2012 405 413
10. S. Kojima et al. The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer J. Hum. Genet. 59 2014 78 87
11. N. Roslan, I. Bieche, R.K. Bright, R. Lidereau, Y. Chen, and J.A. Byrne TPD52 represents a survival factor in ERBB2-amplified breast cancer cells Mol. Carcinog. 2013 10.1002/mc.22038 (Epub ahead of print)
12. M. van Duin et al. High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer Genes Chromosomes Cancer 44 2005 438 449
13. H. Hidaka et al. Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma Oncotarget 3 2012 44 57
14. T. Kinoshita et al. Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma Br. J. Cancer 109 2013 2636 2645
15. N. Kikkawa et al. MiR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC) Br. J. Cancer 103 2010 877 884
16. N. Nohata et al. Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma Br. J. Cancer 105 2011 833 841
17. N. Yanaihara et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis Cancer Cell 9 2006 189 198
18. M.V. Iorio et al. MicroRNA signatures in human ovarian cancer Cancer Res. 67 2007 8699 8707
19. O. Giricz et al. Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity J. Pathol. 226 2012 108 119
20. S. Zhu, M. Sachdeva, F. Wu, Z. Lu, and Y.Y. Mo Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner Oncogene 29 2010 1763 1772
21. N.M. White et al. Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer Br. J. Cancer 102 2010 1244 1253
22. K. Mavridis, K. Stravodimos, and A. Scorilas Downregulation and prognostic performance of microRNA 224 expression in prostate cancer Clin. Chem. 59 2013 261 269
23. Z.Y. Lin et al. MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1 Int. J. Cancer 2013 10.1002/ijc.28707 (Epub ahead of print)
24. D. Ma, X. Tao, F. Gao, C. Fan, and D. Wu MiR-224 functions as an onco-miRNA in hepatocellular carcinoma cells by activating AKT signaling Oncol. Lett. 4 2012 483 488
25. Y. Wang et al. MicroRNA-224 targets SMAD family member 4 to promote cell proliferation and negatively influence patient survival PLoS One 8 2013 e68744
26. Y. Wang et al. Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target J. Biol. Chem. 283 2008 13205 13215
27. C. Scisciani et al. Transcriptional regulation of miR-224 upregulated in human HCCs by NFkappaB inflammatory pathways J. Hepatol. 56 2012 855 861
28. Q. Li et al. MiR-224 promotion of cell migration and invasion by targeting Homeobox D 10 gene in human hepatocellular carcinoma J. Gastroenterol. Hepatol. 29 2014 835 842
29. S.T. Mees, W.A. Mardin, S. Sielker, E. Willscher, N. Senninger, C. Schleicher, M. Colombo-Benkmann, and J. Haier Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas Ann. Surg. Oncol. 16 2009 2339 2350
30. W.T. Liao et al. MicroRNA-224 promotes cell proliferation and tumor growth in human colorectal cancer by repressing PHLPP1 and PHLPP2 Clin. Cancer Res. 19 2013 4662 4672
31. J. Boguslawska, A. Wojcicka, A. Piekielko-Witkowska, A. Master, and A. Nauman MiR-224 targets the 3′UTR of type 1 5′-iodothyronine deiodinase possibly contributing to tissue hypothyroidism in renal cancer PLoS One 6 2011 e24541
32. Q. Li et al. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion J. Gastroenterol. Hepatol. 25 2010 164 171
33. W. Filipowicz, S.N. Bhattacharyya, and N. Sonenberg Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9 2008 102 114
34. R.C. Friedman, K.K. Farh, C.B. Burge, and D.P. Bartel Most mammalian mRNAs are conserved targets of microRNAs Genome Res. 19 2009 92 105
35. J.A. Byrne, C. Tomasetto, J.M. Garnier, N. Rouyer, M.G. Mattei, J.P. Bellocq, M.C. Rio, and P. Basset A screening method to identify genes commonly overexpressed in carcinomas and the identification of a novel complementary DNA sequence Cancer Res. 55 1995 2896 2903
36. V. Shridhar et al. Genetic analysis of early-versus late-stage ovarian tumors Cancer Res. 61 2001 5895 5904
37. M.A. Rubin et al. Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer Cancer Res. 64 2004 3814 3822
38. M.L. Cher et al. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping Cancer Res. 56 1996 3091 3102
39. Y. Chen, A. Kamili, J.R. Hardy, G.E. Groblewski, K.K. Khanna, and J.A. Byrne Tumor protein D52 represents a negative regulator of ATM protein levels Cell Cycle 12 2013 3083 3097
40. P. Tennstedt et al. Patterns of TPD52 overexpression in multiple human solid tumor types analyzed by quantitative PCR Int. J. Oncol. 44 2014 609 615
41. R. Wang et al. PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer Cancer Res. 64 2004 1589 1594
42. R. Wang et al. Transcription variants of the prostate-specific PrLZ gene and their interaction with 14-3-3 proteins Biochem. Biophys. Res. Commun. 389 2009 455 460
43. D. Zhang et al. PrLZ protects prostate cancer cells from apoptosis induced by androgen deprivation via the activation of Stat3/Bcl-2 pathway Cancer Res. 71 2011 2193 2202
44. L. Li et al. Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage Carcinogenesis 34 2013 257 267
45. R. Ummanni, S. Teller, H. Junker, U. Zimmermann, S. Venz, C. Scharf, J. Giebel, and R. Walther Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells FEBS J. 275 2008 5703 5713